The Board denied a compensable rating for dermatophytosis prior to October 19, 2015, and a rating in excess of 30 percent since that date.
The deciding factor: The Veteran's use of topical corticosteroids did not meet the criteria for a compensable or higher rating under the applicable regulations.
- Claimed conditions
- dermatophytosis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- October 12, 2021
- Citation
- 21062823
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Partly granted
The Board granted a 10 percent disability rating for dermatitis, variously diagnosed as seborrheic dermatitis, dermatophytosis, and tinea versicolor, prior to June 5, 2023, but denied a higher rating from that date. The issues related to Raynaud's syndrome and special monthly compensation were remanded.
- Denied
The Board denied increased ratings for multiple service-connected conditions and denied service connection for several additional conditions, granting service connection for headaches.
- Partly granted
The Board denied service connection for acne and remanded several claims, while granting a 10 percent rating for the headache condition from April 11, 2022, to May 5, 2023.
- Denied
The Board denied the veteran's claims for a higher rating for both hypertension and dermatophytosis.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.